[1] 郝天袍,梁飞宇,吴镇洲.血浆脂联素在COPD急性加重期的变化及与其它炎症指标的关系[J].中国医师杂志,2016,18(9):136﹒
[2] KOSKELA HO,SALONEN PH,NISKANEN L.Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease[J].Clin Respir J,2013,7(4):382.
[3] 张卫娟,王啸澜.中老年糖尿病患者低血糖知识认知水平及昏迷的相关因素[J].中国医师杂志,2016,18(6):922﹒
[4] 李华,冯振东,叶树新,等.2型糖尿病患者血液流变学指标与血糖监测指标的相关性分析[J].中国全科医学,2013,16(5C):1763﹒
[5] LI Y,TIAN XX,LIU T,et al.Association between whole blood viscosity and arterial stiffness in patients with type 2 diabetes mellitus[J].Endocrine,2015,49(1):148.
[6] KOSKELA HO,SALONEN PH,ROMPPANEN J,et al.A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality:a prospective,observational cohort study[J].BMJ Open,2015,5(1):e006794.
[7] 张世茹,苏卫华,徐红艳,等.慢性阻塞性肺疾病急性发作期合并糖尿病患者的血栓前状态及抗凝治疗[J].山西医科大学学报,2010,41(7):632﹒
[8] 林武洲,李浪波,陈梅唏,等.慢性阻塞性肺疾病合并2型糖尿病患者凝血、纤溶功能的变化[J].中国实验诊断学,2013,17(5):942﹒
[9] 赵瑞,吴宇晗,邵玉霞.慢性阻塞性肺疾病与糖尿病相关性的研究进展[J].临床肺科杂志,2016,21(10):1900﹒
[10] SAPKOTA B,SHRESTHA SK,POUDEL S.Association of activated partial thromboplastin time and fibrinogen level in patients with type Ⅱ diabetes mellitus[J].BMC Res Notes,2013,6:485.
[11] LIU BH,SUN MX,ZHOU N,et al.Detection and study of plasma D-dimer change in patients with acute exacerbation of chronic obstructive pulmonary disease[J].J Biol Regul Homeost Agents,2016,30(3):839.
[12] ALLINGSTRUP M,WETTERSLEV J,RAVN FB,et al.Antithrombin Ⅲ for critically ill patients:a systematic review with meta-analysis and trial sequential analysis[J].Intensive Care Med,2016,42(4):505.
[13] CORBAN MT,HUNG OY,MEKONNEN G,et al.Elevated levels of serum fibrin and fibrinogen degradation products are independent predictors of larger coronary plaques and greater plaque necrotic core[J].Circ J,2016,80(4):931.
[14] SHI X,LI H.Anticoagulation therapy in patients with chronic obstructive pulmonary disease in the acute exacerbation stage[J].Exp Ther Med,2013,5(5):1367.